Compare ImmunityBio Inc. Common Stock (IBRX) vs Teradata Corporation Common Stock (TDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Teradata Corporation Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10 (market cap $10.39B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 3.7× Teradata Corporation Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Teradata Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 6 Days and Teradata Corporation Common Stock for 0 Days on average.
| IBRX | TDC | |
|---|---|---|
Market Cap | $10.39B | $2.83B |
Volume | 11,509,049 | 1,343,944 |
Sector | Health | Technology |
52-Week High | $11.55 | $37.88 |
52-Week Low | $1.98 | $20.71 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $10.84B | $2.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ImmunityBio (IBRX) trades at $9.80, down 3.16% on the day, amid a bullish technical setup and strong analyst support. The company reported revenue growth to $166 million in 2026 but remains deeply unprofitable with a net loss of $992 million. Recent FDA approval expansion for ANKTIVA in bladder cancer and high-profile executive appointments signal operational momentum, though cash burn remains a concern with negative operating cash flow.
Outlook is cautiously optimistic given the unanimous buy ratings and regulatory milestones, but investment carries high risk due to persistent losses, heavy reliance on financing, and competitive pressures. The stock's trajectory hinges on successful commercialization and pipeline execution to achieve profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Teradata Corporation Common Stock
Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →
